>
>
Ibuprofen API Market – By Type (Standard Ibuprofen, High Potency Ibuprofen), Application (Headache, Arthritis, Fever, Dental Pain), End-use (Pharmaceutical & Biopharmaceutical Companies, CDMOs), Global Forecast (2024 – 2032)
Download Free PDF

Ibuprofen API Market
Get a free sample of this reportGet a free sample of this report Ibuprofen API Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 10
Tables & Figures: 200
Countries covered: 22
Pages: 112
Download Free PDF
Ibuprofen API Market Size
Ibuprofen API Market was valued at USD 694.4 million in 2023 and is anticipated to grow at a CAGR of 3.7% between 2024 – 2032. The increasing prevalence of inflammatory diseases such as arthritis and rheumatoid arthritis has led to a rising demand for ibuprofen API, as it is widely used to alleviate pain and reduce inflammation.
Additionally, the growing geriatric population globally, which is more prone to such conditions, further fuels the demand for ibuprofen API. Moreover, the rising trend of self-medication, supported by the easy availability of over-the-counter ibuprofen products, is also a significant driver of market growth. Furthermore, the expanding pharmaceutical industry and the continual introduction of innovative formulations and combination products containing ibuprofen API are expected to contribute to market expansion in the coming years.
Ibuprofen API refers to the active pharmaceutical ingredient of the medication ibuprofen. Active pharmaceutical ingredients are the biologically active component responsible for the therapeutic effects of the drug. Ibuprofen API is widely used in various formulations such as tablets, capsules, and suspensions, and it is available both over the counter and by prescription.
Ibuprofen API Market Trends
Ibuprofen API Market Analysis
Based on type, the market is segmented into standard ibuprofen and high potency ibuprofen. The high potency ibuprofen segment dominated the market is 2023 and accounted for USD 400.9 million.
Based on application, the ibuprofen API market is segmented into arthritis, headache, fever, dental pain, and other applications. The arthritis segment dominated the market with 31.9% of market share in 2023.
Based on end-use, the ibuprofen API industry is categorized into pharmaceutical & biopharmaceutical companies and CDMO's. The pharmaceutical & biopharmaceutical companies segment dominated the market in 2023 and is predicted to grow at CAGR of 3.4% over the forecast period.
North America ibuprofen API market is anticipated to grow at a CAGR of 3.5% over the forecast years to reach USD 379.5 million by 2032.
U.S. ibuprofen API industry was valued at USD 255.8 million in 2023.
Germany has emerged as a key player in the global market for ibuprofen API, showcasing high growth potential.
India ibuprofen API market is anticipated to witness lucrative growth between 2024 – 2032.
Ibuprofen API Market Share
The ibuprofen API industry is fragmented in nature characterized by the presence of several companies. The key market players are focused on developing improved formulations to obtain a competitive edge in the market. These players are constantly engaged in growth strategies such as partnerships and collaborations, and distribution strategies to enhance their market reach.
Ibuprofen API Market Companies
Prominent players operating in the ibuprofen API industry include:
Ibuprofen API Industry News
The ibuprofen API market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Type
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries: